🇺🇸 Infiltration in United States
14 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 20 April 2025 – 20 April 2026
- Total reports: 14
Most-reported reactions
- Myositis — 3 reports (21.43%)
- Headache — 2 reports (14.29%)
- Pruritus — 2 reports (14.29%)
- Abdominal Pain Upper — 1 report (7.14%)
- Adverse Drug Reaction — 1 report (7.14%)
- Alopecia — 1 report (7.14%)
- Anaphylactoid Reaction — 1 report (7.14%)
- Anticipatory Anxiety — 1 report (7.14%)
- Arthralgia — 1 report (7.14%)
- Asthenia — 1 report (7.14%)
Other Other approved in United States
Frequently asked questions
Is Infiltration approved in United States?
Infiltration does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Infiltration in United States?
University of Seville is the originator. The local marketing authorisation holder may differ — check the official source linked above.